SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

IOL Chemicals & Pharmaceuticals informs about newspaper publication

02 Dec 2021 Evaluate

Pursuant to Regulation 47 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, IOL Chemicals & Pharmaceuticals has informed that it enclosed copy of notice regarding loss of Share Certificates published in 'Economic Times' and 'Punjabi Jagran' on 2nd December 2021.

The above information is a part of company’s filings submitted to BSE.

IOL Chem & Pharma Share Price

140.90 7.30 (5.46%)
29-Jun-2026 14:40 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1870.00
Dr. Reddys Labs. 1383.00
Cipla 1460.05
Zydus Lifesciences 1113.70
Lupin 2379.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: